Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone as an adjuvant to fentanyl-bupivacaine in thoracic paravertebral block analgesia after modified radical mastectomy
PACTR201709002599279Not yet recruiting
- Sponsor
- Tanta University Hospitals
- Start
- Oct 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised trial in postoperative pain comparing Bupivacaine group, Fentanyl group and Naloxone group (3 arms). Primary endpoint: Postoperative pain. Planned start Oct 2017; status: not yet recruiting.
02
Drugs
naloxonefentanylbupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR201709002599279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201709002599279.